Blue Owl Capital saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an increase from 66 to 78.
IBD's unique RS Rating identifies technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the trailing 52 weeks matched up against all other stocks.
History reveals that the stocks that go on to make the biggest gains tend to have an RS Rating of above 80 as they launch their largest price moves. See if Blue Owl Capital can continue to rebound and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
While it's not currently an ideal time to invest, see if the stock is able to establish and enter a buy zone in heavy trade.
The company posted 17% EPS growth in its most recent report. Sales rose 28%.
The company holds the No. 10 rank among its peers in the Finance-Investment Management industry group. P10, Equitable Holdings and Hennessy Advisors are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
